<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gamiño-Arroyo</surname>
    <given-names>A. E.</given-names>
   </name>
   <name>
    <surname>Guerrero</surname>
    <given-names>M. L.</given-names>
   </name>
   <name>
    <surname>McCarthy</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ramírez-Venegas</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Llamosas-Gallardo</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Galindo-Fraga</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2019</year>). 
  <article-title>Efficacy and safety of nitazoxanide in addition to standard of care for the treatment of severe acute respiratory illness</article-title>. 
  <source>Clin. Infect. Dis.</source>
  <volume>69</volume>, 
  <fpage>1903</fpage>–
  <lpage>1911</lpage>. 
  <pub-id pub-id-type="doi">10.1093/cid/ciz100</pub-id>
  <?supplied-pmid 30753384?>
  <pub-id pub-id-type="pmid">30753384</pub-id>
 </mixed-citation>
</ref>
